Marotta John
Marotta John's purchase track record
Marotta John has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/18/2024 | AZTA | $553K | +10.0% | -32.8% | +1.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Beta Bionics and Senseonics announce iLet-Eversense 365 integration. Beta Bionics and Senseonics announced a deal to integrate the iLet automated insulin delivery system with the Eversense 365 continuous glucose monitor. This partnership aims to provide a more seamless solution for patients managing diabetes. The news highlights a strategic move to combine two major technologies in the diabetes care market.
Transaction History
| AZTA | ▲ Buy | Grant | 122,269 | $0 | 11/24/2025 | View on chart |
| AZTA | ▼ Sell | Tax Withholding | 10,980 | $327K | 11/14/2025 | View on chart |
| AZTA | ▼ Sell | Open Market | 316 | $9K | 9/10/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 1,000 | $26K | 6/2/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 1,796 | $50K | 5/9/2025 | View on chart |
| AZTA | ▲ Buy | Grant | 3,638 | $100K | 5/8/2025 | View on chart |
| AZTA | ▲ Buy | Open Market | 1,250 | $51K | 11/19/2024 | View on chart |
| AZTA | ▲ Buy | Open Market | 12,717 | $502K | 11/18/2024 | View on chart |
| AZTA | ▲ Buy | Grant | 83,622 | $3.5M | 11/15/2024 | View on chart |
| AZTA | ▲ Buy | Grant | 3,273 | $151K | 9/9/2024 | View on chart |
| SENS | ▲ Buy | Grant | 66,372 | $0 | 10/31/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
AZTA Featured in Volatile Stock List
Azenta Inc. was included in a recent article discussing volatile stocks with promising prospects. The stock is currently trading within its 52-week range, with analysts maintaining an average price target of $37.00. This mention highlights the company's status as a high-beta asset in the current market environment.
AZTA Featured in Volatile Stock List. Azenta Inc. was included in a recent article discussing volatile stocks with promising prospects. The stock is currently trading within its 52-week range, with analysts maintaining an average price target of $37.00. This mention highlights the company's status as a high-beta asset in the current market environment.